This is a renewal application, now in its 27'^ year. The purpose of this program is to train physician's who will be the future academic leaders in pediatric hematology/oncology. The program provides training at the postdoctoral level in the disciplines of protein chemistry, cell biology, molecular biology, developmental biology, immunology, neuroscience or genetics as they relate to the etiology and pathogenesis of blood disorders and cancer as well as translational/clinical research methodologies important in translating basic discoveries into humans. In this renewal application, new areas of training opportunities in translational research, immunodeficiency and stem cell biology have been outlined. The program primarily trains MD and MD/PhD candidates. It is expected that all MD candidates will receive training equal to a PhD and those who plan on a career in basic science research will receive additional training equivalent to a PhD postdoctoral experience. The training program is individualized for each trainee as they enter the program with different goals and experiences in research. We approach each trainee with the expectation that they will join the faculty of the division of hematology/oncology at Children's Hospital Boston (CHB) and Harvard Medical School as independent investigators following their training period. We have a special interest in training underrepresented minority candidates. Trainees are asked to begin investigating research projects and laboratories during the year before they begin their clinical fellowship. Training takes place in laboratories within the Boston area. The training program also offers significant didactic education. In addition, trainees are expected to attend seminar-style courses, formal lectures, and scientific conferences as well as participate in oral presentations. Training also includes assessment of trainees'ongoing research by trainee- specific scientific oversight committees. The """"""""training faculty"""""""" who will participate in this grant includes subsets of CHB Hematology/Oncology faculty. Hematology faculty of the Brigham and Women's Hospital (BWH), the CHB Stem Cell Program, members of the Immune Disease Institute (IDI), in addition to faculty at other HMS institutions, and the Whitehead Institute and the Broad Institute at MIT. The training faculty have research funds totaling $36,165,934 per year representing 158 NIH grants. The program, seeking renewal for years 29-33 has trained more than 200 individuals and has a significant history of success in training leaders of American hematology and oncology throughout the academic hierarchy.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Chang, Henry
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Children's Hospital Boston
United States
Zip Code
Rowe, R Grant; Daley, George Q (2017) Stem cells: Valine starvation leads to a hungry niche. Nature 541:166-167
Bliss-Moreau, Meghan; Chen, Alyce A; D'Cruz, Akshay A et al. (2017) A motive for killing: effector functions of regulated lytic cell death. Immunol Cell Biol 95:146-151
Feraco, Angela M; Dussel, Veronica; Orellana, Liliana et al. (2017) Tumor Talk and Child Well-Being: Perceptions of ""Good"" and ""Bad"" News Among Parents of Children With Advanced Cancer. J Pain Symptom Manage 53:833-841
Sexauer, Amy N; Tasian, Sarah K (2017) Targeting FLT3 Signaling in Childhood Acute Myeloid Leukemia. Front Pediatr 5:248
Feraco, Angela M; Brand, Sarah R; Mack, Jennifer W et al. (2016) Communication Skills Training in Pediatric Oncology: Moving Beyond Role Modeling. Pediatr Blood Cancer 63:966-72
Tubman, Venée N; Marshall, Roseda; Jallah, Wilhemina et al. (2016) Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study. Pediatr Blood Cancer 63:671-6
Archer, Natasha M; Amorim, Renata Parada; Naves, Rafaela et al. (2016) An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population-Based Evidence for a Cancer Predisposition Syndrome? Pediatr Blood Cancer 63:196-201
Al-Herz, Waleed; Chu, Julia I; van der Spek, Jet et al. (2016) Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol 138:852-859.e3
Pinello, Luca; Canver, Matthew C; Hoban, Megan D et al. (2016) Analyzing CRISPR genome-editing experiments with CRISPResso. Nat Biotechnol 34:695-7
Palchaudhuri, Rahul; Saez, Borja; Hoggatt, Jonathan et al. (2016) Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin. Nat Biotechnol 34:738-45

Showing the most recent 10 out of 77 publications